CUL2 and glioblastoma: Elevated CUL2 expression predicts increased radiosensitivity and dampened signal intensities in perfusion imaging in GBM, suggesting that CUL2 can be integrated as a potential biomarker in facilitating GBM prognosis and radiosensitivity profiling.